The Battle over mTOR: An Emerging Theatre in Host–Pathogen Immunity
暂无分享,去创建一个
[1] M. Gougeon,et al. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells , 2011, Cell Death and Differentiation.
[2] T. Roberts,et al. Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner , 2007, Proceedings of the National Academy of Sciences.
[3] B. Snel,et al. Evolution of the TOR Pathway , 2011, Journal of Molecular Evolution.
[4] J. Cheng,et al. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Winer,et al. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance , 2012, Immunology and cell biology.
[6] Lawrence Steinman,et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.
[7] T. Weichhart,et al. The multiple facets of mTOR in immunity. , 2009, Trends in immunology.
[8] F. McCormick,et al. Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication , 2005, The EMBO journal.
[9] G. McFadden,et al. Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells , 2006, Journal of Virology.
[10] Rohan Kamat,et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function , 2009, Nature Immunology.
[11] M. Horton,et al. Regulation of immune responses by mTOR. , 2012, Annual review of immunology.
[12] J. Gordon,et al. Human nutrition, the gut microbiome and the immune system , 2011, Nature.
[13] Anne E Carpenter,et al. mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.
[14] A. Levine,et al. Role of T antigen interactions with p53 in tumorigenesis. , 2001, Seminars in cancer biology.
[15] O. Schwartz,et al. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. , 2010, Immunity.
[16] J. Alwine,et al. Human Cytomegalovirus Infection Maintains mTOR Activity and Its Perinuclear Localization during Amino Acid Deprivation , 2011, Journal of Virology.
[17] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[18] C. Thompson,et al. The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.
[19] D. Walsh,et al. Regulation of the Translation Initiation Factor eIF4F by Multiple Mechanisms in Human Cytomegalovirus-Infected Cells , 2005, Journal of Virology.
[20] S. Kudchodkar,et al. Effects of Simian Virus 40 Large and Small Tumor Antigens on Mammalian Target of Rapamycin Signaling: Small Tumor Antigen Mediates Hypophosphorylation of eIF4E-Binding Protein 1 Late in Infection , 2005, Journal of Virology.
[21] D. Walsh,et al. Eukaryotic Translation Initiation Factor 4F Architectural Alterations Accompany Translation Initiation Factor Redistribution in Poxvirus-Infected Cells , 2008, Molecular and Cellular Biology.
[22] K. Stuhlmeier,et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.
[23] Yang Ke,et al. Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin* , 2004, Journal of Biological Chemistry.
[24] P. Worley,et al. The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.
[25] A. Awasthi,et al. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses , 2004, Nature Medicine.
[26] R. Ahmed,et al. mTOR regulates memory CD8 T cell differentiation , 2009, Nature.
[27] L. Weiss,et al. Coordinate Control of Host Centrosome Position, Organelle Distribution, and Migratory Response by Toxoplasma gondii via Host mTORC2* , 2010, The Journal of Biological Chemistry.
[28] Craig B. Thompson,et al. Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.
[29] B. Pulendran,et al. Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production , 2010, Proceedings of the National Academy of Sciences.
[30] J. Alwine,et al. The Changing Role of mTOR Kinase in the Maintenance of Protein Synthesis during Human Cytomegalovirus Infection , 2011, Journal of Virology.
[31] D. Walsh,et al. Noncytotoxic Inhibition of Viral Infection through eIF4F-Independent Suppression of Translation by 4EGi-1 , 2010, Journal of Virology.
[32] Y. Natkunam,et al. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. , 2003, Cancer research.
[33] K. Shokat,et al. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. , 2010, Genes & development.
[34] B. Hemmings,et al. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism , 1998, Oncogene.
[35] S. Kudchodkar,et al. AMPK-Mediated Inhibition of mTOR Kinase Is Circumvented during Immediate-Early Times of Human Cytomegalovirus Infection , 2007, Journal of Virology.
[36] A. Miyajima,et al. GM‐CSF triggers a rapid, glucose dependent extracellular acidification by TF‐1 cells: Evidence for sodium/proton antiporter and PKC mediated activation of acid production , 1993, Journal of cellular physiology.
[37] David R. Plas,et al. Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.
[38] D. Walsh,et al. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. , 2004, Genes & development.
[39] D. Pim,et al. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A , 2005, Oncogene.
[40] N. McMillan,et al. Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. , 2006, Virology.
[41] Leaf Huang,et al. In vivo gene delivery by nonviral vectors: overcoming hurdles? , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] Greg M. Delgoffe,et al. mTOR: taking cues from the immune microenvironment , 2009, Immunology.
[43] N. Sonenberg,et al. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. , 2011, Cell host & microbe.
[44] Bruce R. Blazar,et al. Engineering lymphocyte subsets: tools, trials and tribulations , 2009, Nature Reviews Immunology.
[45] B. Finlay,et al. Host–microbe interactions , 2007, Nature.
[46] Qingsheng Li,et al. A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.